Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System)
K-Number: K181128 · 2018-09-06
Device Summary
Frequently Asked Questions
What is the Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System)?
Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System) is a medical device that received FDA 510(k) clearance on 2018-09-06. The listed applicant is Contego Medical, LLC. The 510(k) number is K181128.
When did Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System) receive FDA 510(k) clearance?
Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System) received FDA 510(k) clearance on 2018-09-06, under 510(k) number K181128.
Who is the listed applicant for Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System)?
The FDA 510(k) record lists Contego Medical, LLC as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System)?
The FDA product code for Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System) is LIT.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Contego Medical, LLC as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LIT)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.